Shanghai’s Step Medical Technology has just hit a historic milestone: its Implantable Wireless Brain‑Computer Interface System has been accepted into the National Medical Products Administration’s “innovative medical device special review” – a fast‑track, “green‑channel” pathway reserved for breakthrough products. This makes it the very first invasive brain‑computer interface (BCI) developed in China to receive such priority treatment. The system uses flexible, ultra‑thin electrodes that can be safely implanted in the brain and wirelessly transmit neural signals, a technology that experts say could become the country’s most promising medical‑tech field. The special review process is designed to speed up approval for devices that boast core patents, are domestic firsts, and promise significant clinical benefits. By assigning dedicated reviewers and cutting down bureaucratic steps, the NMDA hopes to shave months off the usual evaluation timeline, helping patients access cutting‑edge therapies sooner. Step Medical’s entry signals both a maturing regulatory environment and a growing confidence in home‑grown neuro‑technology, paving the way for future BCI innovations to move from the lab to the clinic faster than ever before.
Read more